We are live on ! Find out more
OSCR icon

Oscar Health

284 hedge funds and large institutions have $3.78B invested in Oscar Health in 2024 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 102 increasing their positions, 85 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more call options, than puts

Call options by funds: $94.2M | Put options by funds: $37.8M

63% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 38

50% more funds holding in top 10

Funds holding in top 10: 812 (+4)

38% more capital invested

Capital invested by funds: $2.74B → $3.78B (+$1.04B)

20% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 85

9% more funds holding

Funds holding: 261284 (+23)

0.48% more ownership

Funds ownership: 85.79%86.27% (+0.48%)

Holders
284
Holders Change
+23
Holders Change %
+8.81%
% of All Funds
4.08%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
62
Increased
102
Reduced
85
Closed
38
Calls
$94.2M
Puts
$37.8M
Net Calls
+$56.4M
Net Calls Change
+$5.35M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$391M +$18.5M +1,026,676 +6%
BlackRock
2
BlackRock
New York
$328M +$23.3M +1,291,249 +9%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$247M +$6.76M +375,471 +3%
DIG
4
Dragoneer Investment Group
California
$201M -$58.3M -3,238,105 -25%
DM
5
Deerfield Management
New York
$167M +$16.1M +891,888 +13%
Viking Global Investors
6
Viking Global Investors
Connecticut
$131M +$4.4M +244,094 +4%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$114M +$7.77M +431,626 +9%
State Street
8
State Street
Massachusetts
$109M +$5.25M +291,335 +6%
TCMNY
9
Thrive Capital Management (New York)
New York
$101M
Citadel Advisors
10
Citadel Advisors
Florida
$94.8M +$59M +3,276,784 +275%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$92.1M +$8.2M +455,205 +12%
GGHC
12
Gilder Gagnon Howe & Co
New York
$88.8M -$9.91M -550,132 -12%
Capital World Investors
13
Capital World Investors
California
$76.8M +$15.7M +871,586 +32%
Renaissance Technologies
14
Renaissance Technologies
New York
$75.6M -$5.8M -322,000 -8%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$66.5M +$8.68M +481,775 +18%
N
16
Nuveen
North Carolina
$49.5M -$208K -11,574 -0.5%
JP Morgan Chase
17
JP Morgan Chase
New York
$49M +$16.9M +938,742 +69%
GCGM
18
General Catalyst Group Management
Massachusetts
$44.7M
SAM
19
Southeastern Asset Management
Tennessee
$43.6M -$6.19M -343,467 -14%
GCM
20
Glynn Capital Management
California
$40.6M
Northern Trust
21
Northern Trust
Illinois
$37.6M +$7.04M +390,789 +28%
AA
22
Ancient Art
Texas
$37.5M +$12.5M +694,607 +65%
FLAM
23
First Light Asset Management
Minnesota
$37.5M -$1.8M -100,030 -5%
Capital International Investors
24
Capital International Investors
California
$34.5M
ITP
25
Iron Triangle Partners
Connecticut
$34.2M -$3.97M -220,347 -12%

OSCR Hedge Fund Activity: Q3 2024 in Review

284 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q3 2024, worth a combined $3.78B — up 38% from $2.74B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new OSCR positions and 38 closed out — a net gain of 24 holders — while 102 added to existing stakes and 85 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $59M. The largest seller was Dragoneer Investment Group, cutting an estimated $58.3M.

  • 284 institutional investors held Oscar Health (OSCR) as of Q3 2024, up from 261 in Q2 2024.
  • Funds reported $3.78B of Oscar Health stock for Q3 2024, up 38% quarter-over-quarter.
  • 62 funds opened new Oscar Health positions in Q3 2024 and 38 closed out, a net change of +24 holders.
  • The largest Oscar Health buyer in Q3 2024 was Citadel Advisors, an estimated $59M added.
  • The largest Oscar Health seller in Q3 2024 was Dragoneer Investment Group, an estimated $58.3M sold.

Based on aggregated 13F filings for Q3 2024.